Physician

Travis Koeneke, MD

According to 2025 Medicare claims, Travis Koeneke, MD (NPI: 1942305677) practices hematology/oncology in the Manhattan, KS market, with the plurality of this provider's patient population coming from Riley, KS. This provider's primary affiliated billing organization is CANCER CENTER OF KANSAS, P.A. (NPI: 1841251394; TIN: 481181579) and primary practice location at 66502-4861. Koeneke is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287) and Vytalize Health KS 25 LLC (ACO ID: A5671), participating under the MSSP model.

Koeneke's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 807 traditional Medicare patients, billed 640,122 HCPCS/CPT codes, and received $10,026,820 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,492 prescription claims across 479 beneficiaries totaling $5,042,997 in drug costs, led by Lenalidomide (Lenalidomide). DME data shows 59 claims. Open Payments data shows 162 records totaling $2,885. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $3,350,349 to $10,026,820. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $703,022 to $5,042,997. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $18,720 to $696.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	686	365,660	$3,350,349
2016	733	501,549	$4,475,089
2017	812	578,869	$4,578,342
2018	874	609,787	$6,670,738
2019	903	538,098	$6,781,628
2020	873	449,531	$5,832,419
2021	903	413,380	$5,177,922
2022	971	381,868	$6,619,815
2023	1,015	545,391	$8,434,305
2024	807	640,122	$10,026,820

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	184	1,442	$703,022
2016	211	1,396	$1,249,258
2017	222	1,604	$1,372,561
2018	255	1,903	$2,006,588
2019	290	2,058	$2,951,802
2020	296	2,186	$2,156,771
2021	309	2,404	$2,630,423
2022	357	2,498	$2,341,985
2023	432	2,984	$2,873,312
2024	479	3,492	$5,042,997

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	84	388	$81,071
2016	N/R	166	$24,564
2017	N/R	140	$28,262
2018	N/R	57	$7,459
2019	N/R	28	$3,910
2020	N/R	27	$3,966
2021	N/R	47	$3,834
2022	N/R	62	$2,513
2023	N/R	73	$11,368
2024	N/R	59	$1,681

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	356	1,337	$90
96413	Administration of chemotherapy into vein, 1 hour or less	183	1,684	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	408	632	$59
96367	Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less	160	1,895	$20
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	572	1,426	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	38	1,064	$554,055
Cabometyx	Cabozantinib S-Malate	31	916	$495,101
Tasigna	Nilotinib Hcl	24	672	$470,588
Revlimid	Lenalidomide	26	728	$463,260
Pomalyst	Pomalidomide	19	532	$419,701

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	19	$950
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	15	$251
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	13	$245
J8520	Capecitabine, oral, 150 mg	N	N/R	12	$236

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	162	$2,885	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Travis Koeneke, MD?

Tedicare shows public-source Medicare data for Travis Koeneke, MD (NPI 1942305677), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Travis Koeneke, MD have ACO affiliation data?

Travis Koeneke, MD is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287) and Vytalize Health KS 25 LLC (MSSP, ACO ID A5671).

What billing organization is linked to Travis Koeneke, MD?

Travis Koeneke, MD is linked to CANCER CENTER OF KANSAS, P.A. (billing NPI 1841251394) in the available physician profile data.

Does Travis Koeneke, MD have Open Payments data?

Travis Koeneke, MD has 162 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.